Epstein-Barr virus as a marker of biological aggressiveness in breast cancer

C. Mazouni (1, 2) , F. Fina (1) , S. Romain (1) , L'Houcine Ouafik (3) , P. Bonnier (4) , J-M Brandone (5) , P-M Martin (1)

1 Laboratoire de Transfert d'Oncologie Biologique [Hôpital Nord - APHM]
2 Département de chirurgie générale [Gustave Roussy]
3 CRO2 - Centre de Recherches en Oncologie biologique et Oncopharmacologie
4 CHPB - Centre Hospitalier Privé Beauregard.
5 Clinique Bouchard

Although a potential role of the Epstein-Barr virus (EBV) in the pathogenesis of breast cancer (BC) has been underlined, results remain conflicting. Particularly, the impact of EBV infection on biological markers of BC has received little investigation.

Domains: Life Sciences [q-bio]; Cancer

C. Mazouni, F. Fina, S. Romain, L'Houcine Ouafik, P. Bonnier, et al.. Epstein-Barr virus as a marker of biological aggressiveness in breast cancer. British Journal of Cancer, 2011, 104 (2), pp.332 - 337. ⟨10.1038/sj.bjc.6606048⟩. ⟨hal-01827458⟩